The ethical drug company Novo Nordisk will report earnings on Wednesday, January 31. Analysts expect the company to report EPS of $0.67 on revenue of $8.7 billion. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:$NVO Share: Mark W. Guthner, CFA Previous Post Economy & the Cost of Government BorrowingNext PostThe Week Ahead | 1/29/2024 You Might Also Like Southern Copper: SCCO April 29, 2023 INTC: Intel August 26, 2020 After 1 1/2 Year Selloff, Is Time to Get Long Gilead Sciences, Inc. (GILD)? January 5, 2017
You Might Also Like Southern Copper: SCCO April 29, 2023 INTC: Intel August 26, 2020 After 1 1/2 Year Selloff, Is Time to Get Long Gilead Sciences, Inc. (GILD)? January 5, 2017
